CAR-T therapy for multiple sclerosis enters US trials for first time
Nature, Published online: 22 February 2024; doi:10.1038/d41586-024-00470-5Hopes are high that engineered immune cells, which are already in use to treat blood cancer, will halt the progression of a degenerative autoimmune disorder.